RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH. 2000

R Cinti, and L Yin, and K Ilc, and N Berger, and F Basolo, and S Cuccato, and R Giannini, and G Torre, and P Miccoli, and P Amati, and G Romeo, and R Corvi
Istituto G. Gaslini, Laboratorio di Genetica Molecolare and Dipartimento di Oncologia, Biologia e Genetica, Università di Genova, Genova, Italy.

Activation of the RET protooncogene through somatic rearrangements represents the most common genetic alteration in papillary thyroid carcinoma (PTC). Three main rearranged forms of RET have been described: RET/PTC1 and RET/PTC3, which arise from a paracentric inversion of the long arm of chromosome 10, and RET/PTC2, which originates from a 10;17 translocation. We have developed a dual-color FISH approach to detect RET/PTC rearrangements in interphase nuclei of thyroid lesions. By using a pool of three cosmids encompassing the RET chromosome region and a chromosome 10 centromeric probe, we could discriminate between the presence of an inversion (RET/PTC1 and RET/PTC3) or a translocation (RET/PTC2). We have investigated a series of thyroid tissue samples from Italian and French patients corresponding to a total of 69 PTCs and 22 benign lesions. Among PTCs, 13 (18.8%) showed a RET rearrangement, and 11 (15.9%) of these carried an inversion (RET/PTC1 or RET/PTC3) in more than 10% of the nuclei examined. Activated forms of RET were also observed in three adenomas. RT-PCR analysis on the same samples confirmed the presence and the type of rearrangement predicted using FISH analysis. An interesting difference in the frequency and type of RET rearrangements was detected between the Italian and the French patients. Furthermore, we identified a putative novel type of rearrangement in at least one PTC sample. Several PTCs carried a significant number of cells characterized by a trisomy or a tetrasomy of chromosome 10. Overall, the FISH approach in interphase nuclei represents a powerful tool for detecting, at the single cell level, RET/PTC rearrangements and other anomalies involving the RET chromosome region.

UI MeSH Term Description Entries
D007399 Interphase The interval between two successive CELL DIVISIONS during which the CHROMOSOMES are not individually distinguishable. It is composed of the G phases (G1 PHASE; G0 PHASE; G2 PHASE) and S PHASE (when DNA replication occurs). Interphases
D007446 Chromosome Inversion An aberration in which a chromosomal segment is deleted and reinserted in the same place but turned 180 degrees from its original orientation, so that the gene sequence for the segment is reversed with respect to that of the rest of the chromosome. Inversion, Chromosome,Inversion, Chromosomal,Chromosomal Inversion,Chromosomal Inversions,Chromosome Inversions,Inversions, Chromosomal,Inversions, Chromosome
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002291 Carcinoma, Papillary A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed) Carcinomas, Papillary,Papillary Carcinoma,Papillary Carcinomas
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D002503 Centromere The clear constricted portion of the chromosome at which the chromatids are joined and by which the chromosome is attached to the spindle during cell division. Centromeres
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D002879 Chromosomes, Human, Pair 10 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 10
D003360 Cosmids Plasmids containing at least one cos (cohesive-end site) of PHAGE LAMBDA. They are used as cloning vehicles. Cosmid

Related Publications

R Cinti, and L Yin, and K Ilc, and N Berger, and F Basolo, and S Cuccato, and R Giannini, and G Torre, and P Miccoli, and P Amati, and G Romeo, and R Corvi
May 2006, British journal of cancer,
R Cinti, and L Yin, and K Ilc, and N Berger, and F Basolo, and S Cuccato, and R Giannini, and G Torre, and P Miccoli, and P Amati, and G Romeo, and R Corvi
December 2001, Laboratory investigation; a journal of technical methods and pathology,
R Cinti, and L Yin, and K Ilc, and N Berger, and F Basolo, and S Cuccato, and R Giannini, and G Torre, and P Miccoli, and P Amati, and G Romeo, and R Corvi
September 2001, Cancer letters,
R Cinti, and L Yin, and K Ilc, and N Berger, and F Basolo, and S Cuccato, and R Giannini, and G Torre, and P Miccoli, and P Amati, and G Romeo, and R Corvi
January 2011, Journal of biomedicine & biotechnology,
R Cinti, and L Yin, and K Ilc, and N Berger, and F Basolo, and S Cuccato, and R Giannini, and G Torre, and P Miccoli, and P Amati, and G Romeo, and R Corvi
December 1999, Thyroid : official journal of the American Thyroid Association,
R Cinti, and L Yin, and K Ilc, and N Berger, and F Basolo, and S Cuccato, and R Giannini, and G Torre, and P Miccoli, and P Amati, and G Romeo, and R Corvi
January 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
R Cinti, and L Yin, and K Ilc, and N Berger, and F Basolo, and S Cuccato, and R Giannini, and G Torre, and P Miccoli, and P Amati, and G Romeo, and R Corvi
January 2002, International journal of surgical pathology,
R Cinti, and L Yin, and K Ilc, and N Berger, and F Basolo, and S Cuccato, and R Giannini, and G Torre, and P Miccoli, and P Amati, and G Romeo, and R Corvi
September 2005, Cancer,
R Cinti, and L Yin, and K Ilc, and N Berger, and F Basolo, and S Cuccato, and R Giannini, and G Torre, and P Miccoli, and P Amati, and G Romeo, and R Corvi
September 2010, Histopathology,
R Cinti, and L Yin, and K Ilc, and N Berger, and F Basolo, and S Cuccato, and R Giannini, and G Torre, and P Miccoli, and P Amati, and G Romeo, and R Corvi
April 2005, Thyroid : official journal of the American Thyroid Association,
Copied contents to your clipboard!